Behind the scenes of genetics, leukemia in Down syndrome

Children affected by trisomy 21 (or Down syndrome) are 50 to 500 times more likely to develop leukemia than other children.

A group of geneticists working in the Faculty of Medicine at the University of Geneva (UNIGE) focused for many years on the of Down syndrome.

They have sequenced the exome, a specific part of our genome, in a cohort of patients affected both by Down Syndrome and Acute Lymphoblastic Leukaemia (DS-ALL), a type of cancer relative to the cells of the immune system in the .

They were able to sketch an outline of the "genetic identity card" of this disease.

They found that RAS, an important oncogene in many cancers, is involved in the tumorigenesis of one third of DS-ALL cases.

This work is being published in the latest issue of the journal Nature Communications.

add to favorites email to friend print save as pdf

Related Stories

Genetics of cancer: Non-coding DNA can finally be decoded

Jul 23, 2014

Cancer is a disease of the genome resulting from a combination of genetic modifications (or mutations). We inherit from our parents strong or weak predispositions to developing certain kinds of cancer; in addition, we also ...

Key player found for a cancer typical in Down syndrome

Mar 01, 2010

Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more ...

Recommended for you

New research software automates DNA analysis

17 hours ago

At the core of medical research is problem-solving, which is exactly what two PhD scientists did when they set out to eliminate a common, time-consuming task performed in research laboratories around the world.

User comments